|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
224 a.a.
|
 |
|
|
|
|
|
|
|
1113 a.a.
|
 |
|
|
|
|
|
|
|
1174 a.a.
|
 |
|
|
|
|
|
|
|
98 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Thermus aquaticus core RNA polymerase-rifampicin complex
|
|
Structure:
|
 |
DNA-directed RNA polymerase. Chain: a, b. Fragment: alpha subunit. DNA-directed RNA polymerase. Chain: c. Fragment: beta subunit. DNA-directed RNA polymerase. Chain: d. Fragment: beta-prime subunit.
|
|
Source:
|
 |
Thermus aquaticus. Organism_taxid: 271. Organism_taxid: 271
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
3.30Å
|
R-factor:
|
0.276
|
R-free:
|
0.359
|
|
|
Authors:
|
 |
E.A.Campbell,N.Korzheva,A.Mustaev,K.Murakami,A.Goldfarb, S.A.Darst
|
Key ref:
|
 |
E.A.Campbell
et al.
(2001).
Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
Cell,
104,
901-912.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Mar-01
|
Release date:
|
18-Apr-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9KWU8
(RPOA_THEAQ) -
DNA-directed RNA polymerase subunit alpha
|
|
|
|
Seq: Struc:
|
 |
 |
 |
314 a.a.
224 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q9KWU7
(RPOB_THEAQ) -
DNA-directed RNA polymerase subunit beta
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1119 a.a.
1113 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E:
E.C.2.7.7.6
- DNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1)
|
 |
 |
 |
 |
 |
Nucleoside triphosphate
|
+
|
RNA(n)
|
=
|
diphosphate
|
+
|
RNA(n+1)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
RNA polymerase complex
|
1 term
|
 |
|
Biological process
|
DNA repair
|
3 terms
|
 |
|
Biochemical function
|
transferase activity
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Cell
104:901-912
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
|
|
E.A.Campbell,
N.Korzheva,
A.Mustaev,
K.Murakami,
S.Nair,
A.Goldfarb,
S.A.Darst.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Rifampicin (Rif) is one of the most potent and broad spectrum antibiotics
against bacterial pathogens and is a key component of anti-tuberculosis therapy,
stemming from its inhibition of the bacterial RNA polymerase (RNAP). We
determined the crystal structure of Thermus aquaticus core RNAP complexed with
Rif. The inhibitor binds in a pocket of the RNAP beta subunit deep within the
DNA/RNA channel, but more than 12 A away from the active site. The structure,
combined with biochemical results, explains the effects of Rif on RNAP function
and indicates that the inhibitor acts by directly blocking the path of the
elongating RNA when the transcript becomes 2 to 3 nt in length.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Detailed Interactions of Rif with RNAP(a) Stereo
view of the Taq RNAP Rif binding pocket complexed with Rif,
generated using RIBBONS (Carson, 1991), showing residues that
interact directly with the inhibitor. The view is from the top
of the RNAP in Figure 3b, above the β subunit, looking down
through β to the Rif, but with obscuring parts of β removed.
The backbone of the β subunit is shown as a cyan ribbon. Side
chains (and backbone atoms of F394) of residues within 4 Å
of Rif are shown. Carbon atoms are orange (Rif), magenta (three
residues substituted in M. tuberculosis Rif^R clinical isolates
with high frequency, see Figure 1), or yellow; oxygen atoms are
red; nitrogen atoms are blue. Potential hydrogen bonds between
protein atoms and Rif are shown as dashed lines.(b) Schematic
drawing of RNAP β subunit interactions with Rif, modified from
LIGPLOT (Wallace et al., 1995). Residues forming van der Waals
interactions are indicated, those participating in hydrogen
bonds are shown in a ball-and-stick representation, with
hydrogen bonds depicted as dashed lines. Carbon atoms of the
protein are black, while carbon atoms of Rif are orange. Oxygen
atoms are red and nitrogen atoms are blue
|
 |
Figure 6.
Figure 6. Mechanism of RNAP Inhibition by Rif(a) The RNAP
active site Mg^2+ (magenta sphere) and the 9 bp RNA/DNA hybrid
(from +1 to −8) from a model of the ternary elongation complex
(Korzheva et al., 2000) are shown. The RNAP itself and the rest
of the nucleic acids are omitted for clarity. The incoming
nucleotide substrate at the +1 position is colored green, the
−1 and −2 positions, which can be accommodated in the
presence of Rif, are colored yellow. The RNA further upstream
(−3 to −8), which cannot be accommodated in the presence of
Rif, is colored pink. The template strand of the DNA is colored
gray. Also shown is a CPK representation of Rif as it would be
positioned in its binding site on the β subunit (carbon atoms,
orange; oxygen, red; nitrogen, blue). The Rif is partially
transparent, illustrating the RNA nucleotides at −3 to −5
that sterically clash. Generated using GRASP (Nicholls et al.,
1991).(b) The structure of the minimal scaffold systems with RNA
lengths from 3–7 nt (labeled above the RNA chain; Korzheva et
al., 2000). The results are presented below as autoradiographs
of the radioactive RNAs produced by E. coli (lanes 1–15) or
Taq (lanes 16–30) core RNAPs transcribing the minimal
scaffolds with the indicated lengths of RNA (“X =â€) and
analyzed on a 23% polyacrylamide gel. Lanes 1–10 and 16–25
demonstrate the effect of Rif inhibition of transcription when
it was bound by RNAP either before (lanes 1–5 and 16–20) or
after (lanes 6–10 and lanes 21–25) addition of the scaffold.
Lanes 11–15 and 26–30 show elongation of the same scaffolds
in the absence of Rif. The RNA with the critical length of 3 nt,
which cannot be elongated by E. coli RNAP in the presence of Rif
regardless of the order of Rif and scaffold addition (lanes 1
and 6), is colored red. The RNAs of 4–7 nt (colored green)
were extended by E. coli RNAP when added before Rif (lanes
6–10)
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2001,
104,
901-912)
copyright 2001.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Koul,
E.Arnoult,
N.Lounis,
J.Guillemont,
and
K.Andries
(2011).
The challenge of new drug discovery for tuberculosis.
|
| |
Nature, 469,
483-490.
|
 |
|
|
|
|
 |
E.Miyahara,
M.Nishie,
S.Takumi,
H.Miyanohara,
J.Nishi,
K.Yoshiie,
H.Oda,
M.Takeuchi,
M.Komatsu,
K.Aoyama,
M.Horiuchi,
and
T.Takeuchi
(2011).
Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms.
|
| |
FEMS Microbiol Lett, 317,
109-116.
|
 |
|
|
|
|
 |
M.Villar,
J.M.Marimón,
J.M.García-Arenzana,
A.G.de la Campa,
M.J.Ferrándiz,
and
E.Pérez-Trallero
(2011).
Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.
|
| |
J Antimicrob Chemother, 66,
997.
|
 |
|
|
|
|
 |
P.Ascenzi,
A.Bolli,
A.di Masi,
G.R.Tundo,
G.Fanali,
M.Coletta,
and
M.Fasano
(2011).
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.
|
| |
J Biol Inorg Chem, 16,
97.
|
 |
|
|
|
|
 |
T.I.Moy,
A.Daniel,
C.Hardy,
A.Jackson,
O.Rehrauer,
Y.S.Hwang,
D.Zou,
K.Nguyen,
J.A.Silverman,
Q.Li,
and
C.Murphy
(2011).
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus.
|
| |
FEMS Microbiol Lett, 319,
176-179.
|
 |
|
|
|
|
 |
T.Inaoka,
and
K.Ochi
(2011).
Activation of Dormant Secondary Metabolism Neotrehalosadiamine Synthesis by an RNA Polymerase Mutation in Bacillus subtilis.
|
| |
Biosci Biotechnol Biochem, 75,
618-623.
|
 |
|
|
|
|
 |
A.R.Hall,
V.F.Griffiths,
R.C.MacLean,
and
N.Colegrave
(2010).
Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa.
|
| |
Proc Biol Sci, 277,
643-650.
|
 |
|
|
|
|
 |
A.Tupin,
M.Gualtieri,
J.P.Leonetti,
and
K.Brodolin
(2010).
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site.
|
| |
EMBO J, 29,
2527-2537.
|
 |
|
|
|
|
 |
C.Steglich,
D.Lindell,
M.Futschik,
T.Rector,
R.Steen,
and
S.W.Chisholm
(2010).
Short RNA half-lives in the slow-growing marine cyanobacterium Prochlorococcus.
|
| |
Genome Biol, 11,
R54.
|
 |
|
|
|
|
 |
G.N.Forrest,
and
K.Tamura
(2010).
Rifampin combination therapy for nonmycobacterial infections.
|
| |
Clin Microbiol Rev, 23,
14-34.
|
 |
|
|
|
|
 |
H.Asahara,
and
S.Chong
(2010).
In vitro genetic reconstruction of bacterial transcription initiation by coupled synthesis and detection of RNA polymerase holoenzyme.
|
| |
Nucleic Acids Res, 38,
e141.
|
 |
|
|
|
|
 |
K.Zhao,
M.Liu,
and
R.R.Burgess
(2010).
Promoter and regulon analysis of nitrogen assimilation factor, sigma54, reveal alternative strategy for E. coli MG1655 flagellar biosynthesis.
|
| |
Nucleic Acids Res, 38,
1273-1283.
|
 |
|
|
|
|
 |
M.A.Kohanski,
D.J.Dwyer,
and
J.J.Collins
(2010).
How antibiotics kill bacteria: from targets to networks.
|
| |
Nat Rev Microbiol, 8,
423-435.
|
 |
|
|
|
|
 |
M.Sánchez-Hidalgo,
L.E.Núñez,
C.Méndez,
and
J.A.Salas
(2010).
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
|
| |
Antimicrob Agents Chemother, 54,
1684-1692.
|
 |
|
|
|
|
 |
M.Z.Ahmed,
S.X.Ren,
X.Xue,
X.X.Li,
G.H.Jin,
and
B.L.Qiu
(2010).
Prevalence of endosymbionts in Bemisia tabaci populations and their in vivo sensitivity to antibiotics.
|
| |
Curr Microbiol, 61,
322-328.
|
 |
|
|
|
|
 |
R.C.MacLean,
A.R.Hall,
G.G.Perron,
and
A.Buckling
(2010).
The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.
|
| |
Nat Rev Genet, 11,
405-414.
|
 |
|
|
|
|
 |
R.Moeller,
G.Reitz,
T.Berger,
R.Okayasu,
W.L.Nicholson,
and
G.Horneck
(2010).
Astrobiological aspects of the mutagenesis of cosmic radiation on bacterial spores.
|
| |
Astrobiology, 10,
509-521.
|
 |
|
|
|
|
 |
S.Patrick,
G.W.Blakely,
S.Houston,
J.Moore,
V.R.Abratt,
M.Bertalan,
A.M.Cerdeño-Tárraga,
M.A.Quail,
N.Corton,
C.Corton,
A.Bignell,
A.Barron,
L.Clark,
S.D.Bentley,
and
J.Parkhill
(2010).
Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis.
|
| |
Microbiology, 156,
3255-3269.
|
 |
|
|
|
|
 |
V.Malshetty,
K.Kurthkoti,
A.China,
B.Mallick,
S.Yamunadevi,
P.B.Sang,
N.Srinivasan,
V.Nagaraja,
and
U.Varshney
(2010).
Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription.
|
| |
Microbiology, 156,
1565-1573.
|
 |
|
|
|
|
 |
W.J.Lane,
and
S.A.Darst
(2010).
Molecular evolution of multisubunit RNA polymerases: structural analysis.
|
| |
J Mol Biol, 395,
686-704.
|
 |
|
|
|
|
 |
C.L.Stallings,
N.C.Stephanou,
L.Chu,
A.Hochschild,
B.E.Nickels,
and
M.S.Glickman
(2009).
CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence.
|
| |
Cell, 138,
146-159.
|
 |
|
|
|
|
 |
C.Olano,
C.Gómez,
M.Pérez,
M.Palomino,
A.Pineda-Lucena,
R.J.Carbajo,
A.F.Braña,
C.Méndez,
and
J.A.Salas
(2009).
Deciphering biosynthesis of the RNA polymerase inhibitor streptolydigin and generation of glycosylated derivatives.
|
| |
Chem Biol, 16,
1031-1044.
|
 |
|
|
|
|
 |
C.Sala,
D.C.Grainger,
and
S.T.Cole
(2009).
Dissecting regulatory networks in host-pathogen interaction using chIP-on-chip technology.
|
| |
Cell Host Microbe, 5,
430-437.
|
 |
|
|
|
|
 |
D.G.Vassylyev
(2009).
Elongation by RNA polymerase: a race through roadblocks.
|
| |
Curr Opin Struct Biol, 19,
691-700.
|
 |
|
|
|
|
 |
E.Nudler
(2009).
RNA polymerase active center: the molecular engine of transcription.
|
| |
Annu Rev Biochem, 78,
335-361.
|
 |
|
|
|
|
 |
G.Riccardi,
M.R.Pasca,
and
S.Buroni
(2009).
Mycobacterium tuberculosis: drug resistance and future perspectives.
|
| |
Future Microbiol, 4,
597-614.
|
 |
|
|
|
|
 |
J.Pan,
L.Lin,
and
Y.J.Tao
(2009).
Self-guanylylation of birnavirus VP1 does not require an intact polymerase activity site.
|
| |
Virology, 395,
87-96.
|
 |
|
|
|
|
 |
M.Dehbi,
G.Moeck,
F.F.Arhin,
P.Bauda,
D.Bergeron,
T.Kwan,
J.Liu,
J.McCarty,
M.Dubow,
and
J.Pelletier
(2009).
Inhibition of transcription in Staphylococcus aureus by a primary sigma factor-binding polypeptide from phage G1.
|
| |
J Bacteriol, 191,
3763-3771.
|
 |
|
|
|
|
 |
M.X.Ho,
B.P.Hudson,
K.Das,
E.Arnold,
and
R.H.Ebright
(2009).
Structures of RNA polymerase-antibiotic complexes.
|
| |
Curr Opin Struct Biol, 19,
715-723.
|
 |
|
|
|
|
 |
N.Pike,
and
R.Kingcombe
(2009).
Antibiotic treatment leads to the elimination of Wolbachia endosymbionts and sterility in the diplodiploid collembolan Folsomia candida.
|
| |
BMC Biol, 7,
54.
|
 |
|
|
|
|
 |
N.R.Morero,
and
C.E.Argaraña
(2009).
Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin.
|
| |
FEMS Microbiol Lett, 290,
217-226.
|
 |
|
|
|
|
 |
R.C.MacLean,
and
A.Buckling
(2009).
The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa.
|
| |
PLoS Genet, 5,
e1000406.
|
 |
|
|
|
|
 |
Y.Chai,
and
S.C.Winans
(2009).
The chaperone GroESL enhances the accumulation of soluble, active TraR protein, a quorum-sensing transcription factor from Agrobacterium tumefaciens.
|
| |
J Bacteriol, 191,
3706-3711.
|
 |
|
|
|
|
 |
Y.Korkhin,
U.M.Unligil,
O.Littlefield,
P.J.Nelson,
D.I.Stuart,
P.B.Sigler,
S.D.Bell,
and
N.G.Abrescia
(2009).
Evolution of Complex RNA Polymerases: The Complete Archaeal RNA Polymerase Structure.
|
| |
PLoS Biol, 7,
e102.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.E.Perkins,
A.C.Schuerger,
and
W.L.Nicholson
(2008).
Isolation of rpoB mutations causing rifampicin resistance in Bacillus subtilis spores exposed to simulated Martian surface conditions.
|
| |
Astrobiology, 8,
1159-1167.
|
 |
|
|
|
|
 |
A.Feklistov,
V.Mekler,
Q.Jiang,
L.F.Westblade,
H.Irschik,
R.Jansen,
A.Mustaev,
S.A.Darst,
and
R.H.Ebright
(2008).
Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center.
|
| |
Proc Natl Acad Sci U S A, 105,
14820-14825.
|
 |
|
|
|
|
 |
A.Hirata,
B.J.Klein,
and
K.S.Murakami
(2008).
The X-ray crystal structure of RNA polymerase from Archaea.
|
| |
Nature, 451,
851-854.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.K.Cho,
C.L.Barrett,
E.M.Knight,
Y.S.Park,
and
B.Ã.˜.Palsson
(2008).
Genome-scale reconstruction of the Lrp regulatory network in Escherichia coli.
|
| |
Proc Natl Acad Sci U S A, 105,
19462-19467.
|
 |
|
|
|
|
 |
C.Sala,
F.Forti,
F.Magnoni,
and
D.Ghisotti
(2008).
The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation.
|
| |
BMC Mol Biol, 9,
33.
|
 |
|
|
|
|
 |
D.M.Rothstein,
R.J.Suchland,
M.Xia,
C.K.Murphy,
and
W.E.Stamm
(2008).
Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.
|
| |
J Antibiot (Tokyo), 61,
489-495.
|
 |
|
|
|
|
 |
D.R.Beckler,
S.Elwasila,
G.Ghobrial,
J.F.Valentine,
and
S.A.Naser
(2008).
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.
|
| |
World J Gastroenterol, 14,
2723-2730.
|
 |
|
|
|
|
 |
E.Varhimo,
K.Savijoki,
H.Jefremoff,
J.Jalava,
A.Sukura,
and
P.Varmanen
(2008).
Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis.
|
| |
Environ Microbiol, 10,
2179-2183.
|
 |
|
|
|
|
 |
J.Baysarowich,
K.Koteva,
D.W.Hughes,
L.Ejim,
E.Griffiths,
K.Zhang,
M.Junop,
and
G.D.Wright
(2008).
Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.
|
| |
Proc Natl Acad Sci U S A, 105,
4886-4891.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Mukhopadhyay,
K.Das,
S.Ismail,
D.Koppstein,
M.Jang,
B.Hudson,
S.Sarafianos,
S.Tuske,
J.Patel,
R.Jansen,
H.Irschik,
E.Arnold,
and
R.H.Ebright
(2008).
The RNA polymerase "switch region" is a target for inhibitors.
|
| |
Cell, 135,
295-307.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.R.O'Connor,
M.A.Galang,
S.P.Sambol,
D.W.Hecht,
G.Vedantam,
D.N.Gerding,
and
S.Johnson
(2008).
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
|
| |
Antimicrob Agents Chemother, 52,
2813-2817.
|
 |
|
|
|
|
 |
N.Durán,
M.A.Alvarenga,
E.C.Da Silva,
P.S.Melo,
and
P.D.Marcato
(2008).
Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
|
| |
Arch Pharm Res, 31,
1509-1516.
|
 |
|
|
|
|
 |
P.R.Cortes,
G.E.Piñas,
A.G.Albarracin Orio,
and
J.R.Echenique
(2008).
Subinhibitory concentrations of penicillin increase the mutation rate to optochin resistance in Streptococcus pneumoniae.
|
| |
J Antimicrob Chemother, 62,
973-977.
|
 |
|
|
|
|
 |
R.Sousa
(2008).
Tie me up, tie me down: inhibiting RNA polymerase.
|
| |
Cell, 135,
205-207.
|
 |
|
|
|
|
 |
S.Borukhov,
and
E.Nudler
(2008).
RNA polymerase: the vehicle of transcription.
|
| |
Trends Microbiol, 16,
126-134.
|
 |
|
|
|
|
 |
S.Takumi,
M.Komatsu,
K.Aoyama,
K.Watanabe,
and
T.Takeuchi
(2008).
Oxygen induces mutation in a strict anaerobe, Prevotella melaninogenica.
|
| |
Free Radic Biol Med, 44,
1857-1862.
|
 |
|
|
|
|
 |
A.K.Ganesan,
A.J.Smith,
N.J.Savery,
P.Zamos,
and
P.C.Hanawalt
(2007).
Transcription coupled nucleotide excision repair in Escherichia coli can be affected by changing the arginine at position 529 of the beta subunit of RNA polymerase.
|
| |
DNA Repair (Amst), 6,
1434-1440.
|
 |
|
|
|
|
 |
A.Szalewska-Palasz,
G.Wegrzyn,
and
A.Wegrzyn
(2007).
Mechanisms of physiological regulation of RNA synthesis in bacteria: new discoveries breaking old schemes.
|
| |
J Appl Genet, 48,
281-294.
|
 |
|
|
|
|
 |
C.E.César,
and
M.Llosa
(2007).
TrwC-mediated site-specific recombination is controlled by host factors altering local DNA topology.
|
| |
J Bacteriol, 189,
9037-9043.
|
 |
|
|
|
|
 |
C.K.Murphy,
E.Karginova,
D.Sahm,
and
D.M.Rothstein
(2007).
In vitro activity of novel rifamycins against gram-positive clinical isolates.
|
| |
J Antibiot (Tokyo), 60,
572-576.
|
 |
|
|
|
|
 |
D.M.Rothstein,
J.van Duzer,
A.Sternlicht,
and
S.C.Gilman
(2007).
Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.
|
| |
Arch Pharm (Weinheim), 340,
517-529.
|
 |
|
|
|
|
 |
E.G.Medrano,
and
A.A.Bell
(2007).
Role of Pantoea agglomerans in opportunistic bacterial seed and boll rot of cotton (Gossypium hirsutum) grown in the field.
|
| |
J Appl Microbiol, 102,
134-143.
|
 |
|
|
|
|
 |
E.Varhimo,
K.Savijoki,
J.Jalava,
O.P.Kuipers,
and
P.Varmanen
(2007).
Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.
|
| |
J Bacteriol, 189,
5210-5222.
|
 |
|
|
|
|
 |
M.Suzuki,
L.Mao,
and
M.Inouye
(2007).
Single protein production (SPP) system in Escherichia coli.
|
| |
Nat Protoc, 2,
1802-1810.
|
 |
|
|
|
|
 |
V.Nagarajavel,
S.Madhusudan,
S.Dole,
A.R.Rahmouni,
and
K.Schnetz
(2007).
Repression by binding of H-NS within the transcription unit.
|
| |
J Biol Chem, 282,
23622-23630.
|
 |
|
|
|
|
 |
A.J.O'Neill,
T.Huovinen,
C.W.Fishwick,
and
I.Chopra
(2006).
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.
|
| |
Antimicrob Agents Chemother, 50,
298-309.
|
 |
|
|
|
|
 |
A.N.Kapanidis,
E.Margeat,
S.O.Ho,
E.Kortkhonjia,
S.Weiss,
and
R.H.Ebright
(2006).
Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism.
|
| |
Science, 314,
1144-1147.
|
 |
|
|
|
|
 |
A.Ruffing,
Z.Mao,
and
R.Ruizhen Chen
(2006).
Metabolic engineering of Agrobacterium sp. for UDP-galactose regeneration and oligosaccharide synthesis.
|
| |
Metab Eng, 8,
465-473.
|
 |
|
|
|
|
 |
C.K.Murphy,
S.Mullin,
M.S.Osburne,
J.van Duzer,
J.Siedlecki,
X.Yu,
K.Kerstein,
M.Cynamon,
and
D.M.Rothstein
(2006).
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
|
| |
Antimicrob Agents Chemother, 50,
827-834.
|
 |
|
|
|
|
 |
E.Kashkina,
M.Anikin,
T.H.Tahirov,
S.N.Kochetkov,
D.G.Vassylyev,
and
D.Temiakov
(2006).
Elongation complexes of Thermus thermophilus RNA polymerase that possess distinct translocation conformations.
|
| |
Nucleic Acids Res, 34,
4036-4045.
|
 |
|
|
|
|
 |
G.Yim,
F.de la Cruz,
G.B.Spiegelman,
and
J.Davies
(2006).
Transcription modulation of Salmonella enterica serovar Typhimurium promoters by sub-MIC levels of rifampin.
|
| |
J Bacteriol, 188,
7988-7991.
|
 |
|
|
|
|
 |
H.Yoneyama,
and
R.Katsumata
(2006).
Antibiotic resistance in bacteria and its future for novel antibiotic development.
|
| |
Biosci Biotechnol Biochem, 70,
1060-1075.
|
 |
|
|
|
|
 |
J.Davies,
G.B.Spiegelman,
and
G.Yim
(2006).
The world of subinhibitory antibiotic concentrations.
|
| |
Curr Opin Microbiol, 9,
445-453.
|
 |
|
|
|
|
 |
J.Varaldi,
M.Ravallec,
C.Labrosse,
M.Lopez-Ferber,
M.Boulétreau,
and
F.Fleury
(2006).
Artifical transfer and morphological description of virus particles associated with superparasitism behaviour in a parasitoid wasp.
|
| |
J Insect Physiol, 52,
1202-1212.
|
 |
|
|
|
|
 |
K.V.Newell,
D.P.Thomas,
D.Brekasis,
and
M.S.Paget
(2006).
The RNA polymerase-binding protein RbpA confers basal levels of rifampicin resistance on Streptomyces coelicolor.
|
| |
Mol Microbiol, 60,
687-696.
|
 |
|
|
|
|
 |
L.Falzon,
M.Suzuki,
and
M.Inouye
(2006).
Finding one of a kind: advances in single-protein production.
|
| |
Curr Opin Biotechnol, 17,
347-352.
|
 |
|
|
|
|
 |
S.F.Holmes,
T.J.Santangelo,
C.K.Cunningham,
J.W.Roberts,
and
D.A.Erie
(2006).
Kinetic investigation of Escherichia coli RNA polymerase mutants that influence nucleotide discrimination and transcription fidelity.
|
| |
J Biol Chem, 281,
18677-18683.
|
 |
|
|
|
|
 |
V.Trinh,
M.F.Langelier,
J.Archambault,
and
B.Coulombe
(2006).
Structural perspective on mutations affecting the function of multisubunit RNA polymerases.
|
| |
Microbiol Mol Biol Rev, 70,
12-36.
|
 |
|
|
|
|
 |
W.S.Kontur,
R.M.Saecker,
C.A.Davis,
M.W.Capp,
and
M.T.Record
(2006).
Solute probes of conformational changes in open complex (RPo) formation by Escherichia coli RNA polymerase at the lambdaPR promoter: evidence for unmasking of the active site in the isomerization step and for large-scale coupled folding in the subsequent conversion to RPo.
|
| |
Biochemistry, 45,
2161-2177.
|
 |
|
|
|
|
 |
C.D.Herring,
M.Raffaelle,
T.E.Allen,
E.I.Kanin,
R.Landick,
A.Z.Ansari,
and
B.Ã.˜.Palsson
(2005).
Immobilization of Escherichia coli RNA polymerase and location of binding sites by use of chromatin immunoprecipitation and microarrays.
|
| |
J Bacteriol, 187,
6166-6174.
|
 |
|
|
|
|
 |
E.A.Campbell,
O.Pavlova,
N.Zenkin,
F.Leon,
H.Irschik,
R.Jansen,
K.Severinov,
and
S.A.Darst
(2005).
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase.
|
| |
EMBO J, 24,
674-682.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.d.e. .J.dos Santos,
V.F.Ximenes,
L.M.da Fonseca,
O.M.de Faria Oliveira,
and
I.L.Brunetti
(2005).
Horseradish peroxidase-catalyzed oxidation of rifampicin: reaction rate enhancement by co-oxidation with anti-inflammatory drugs.
|
| |
Biol Pharm Bull, 28,
1822-1826.
|
 |
|
|
|
|
 |
I.Artsimovitch,
M.N.Vassylyeva,
D.Svetlov,
V.Svetlov,
A.Perederina,
N.Igarashi,
N.Matsugaki,
S.Wakatsuki,
T.H.Tahirov,
and
D.G.Vassylyev
(2005).
Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.
|
| |
Cell, 122,
351-363.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.L.Knight,
V.Mekler,
J.Mukhopadhyay,
R.H.Ebright,
and
R.M.Levy
(2005).
Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability.
|
| |
Biophys J, 88,
925-938.
|
 |
|
|
|
|
 |
M.J.Ferrándiz,
C.Ardanuy,
J.Liñares,
J.M.García-Arenzana,
E.Cercenado,
A.Fleites,
and
A.G.de la Campa
(2005).
New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.
|
| |
Antimicrob Agents Chemother, 49,
2237-2245.
|
 |
|
|
|
|
 |
M.Raffaelle,
E.I.Kanin,
J.Vogt,
R.R.Burgess,
and
A.Z.Ansari
(2005).
Holoenzyme switching and stochastic release of sigma factors from RNA polymerase in vivo.
|
| |
Mol Cell, 20,
357-366.
|
 |
|
|
|
|
 |
M.Xia,
R.J.Suchland,
J.A.Carswell,
J.Van Duzer,
D.K.Buxton,
K.Brown,
D.M.Rothstein,
and
W.E.Stamm
(2005).
Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.
|
| |
Antimicrob Agents Chemother, 49,
3974-3976.
|
 |
|
|
|
|
 |
M.Xu,
Y.N.Zhou,
B.P.Goldstein,
and
D.J.Jin
(2005).
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.
|
| |
J Bacteriol, 187,
2783-2792.
|
 |
|
|
|
|
 |
N.Kawamura,
K.Kurokawa,
T.Ito,
H.Hamamoto,
H.Koyama,
C.Kaito,
and
K.Sekimizu
(2005).
Participation of Rho-dependent transcription termination in oxidative stress sensitivity caused by an rpoB mutation.
|
| |
Genes Cells, 10,
477-487.
|
 |
|
|
|
|
 |
N.Zenkin,
A.Kulbachinskiy,
I.Bass,
and
V.Nikiforov
(2005).
Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.
|
| |
Antimicrob Agents Chemother, 49,
1587-1590.
|
 |
|
|
|
|
 |
R.J.Suchland,
A.Bourillon,
E.Denamur,
W.E.Stamm,
and
D.M.Rothstein
(2005).
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
|
| |
Antimicrob Agents Chemother, 49,
1120-1126.
|
 |
|
|
|
|
 |
R.M.Anthony,
A.R.Schuitema,
I.L.Bergval,
T.J.Brown,
L.Oskam,
and
P.R.Klatser
(2005).
Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
|
| |
Ann Clin Microbiol Antimicrob, 4,
9.
|
 |
|
|
|
|
 |
S.Reckel,
F.Löhr,
and
V.Dötsch
(2005).
In-cell NMR spectroscopy.
|
| |
Chembiochem, 6,
1601-1606.
|
 |
|
|
|
|
 |
S.Tuske,
S.G.Sarafianos,
X.Wang,
B.Hudson,
E.Sineva,
J.Mukhopadhyay,
J.J.Birktoft,
O.Leroy,
S.Ismail,
A.D.Clark,
C.Dharia,
A.Napoli,
O.Laptenko,
J.Lee,
S.Borukhov,
R.H.Ebright,
and
E.Arnold
(2005).
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation.
|
| |
Cell, 122,
541-552.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Xiong,
X.Wu,
and
T.Mahmud
(2005).
A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
|
| |
Chembiochem, 6,
834-837.
|
 |
|
|
|
|
 |
A.Kulbachinskiy,
A.Feklistov,
I.Krasheninnikov,
A.Goldfarb,
and
V.Nikiforov
(2004).
Aptamers to Escherichia coli core RNA polymerase that sense its interaction with rifampicin, sigma-subunit and GreB.
|
| |
Eur J Biochem, 271,
4921-4931.
|
 |
|
|
|
|
 |
C.Marianelli,
F.Ciuchini,
M.Tarantino,
P.Pasquali,
and
R.Adone
(2004).
Genetic bases of the rifampin resistance phenotype in Brucella spp.
|
| |
J Clin Microbiol, 42,
5439-5443.
|
 |
|
|
|
|
 |
C.Prins,
S.G.Cresawn,
and
R.C.Condit
(2004).
An isatin-beta-thiosemicarbazone-resistant vaccinia virus containing a mutation in the second largest subunit of the viral RNA polymerase is defective in transcription elongation.
|
| |
J Biol Chem, 279,
44858-44871.
|
 |
|
|
|
|
 |
E.Sarubbi,
F.Monti,
E.Corti,
A.Miele,
and
E.Selva
(2004).
Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase.
|
| |
Eur J Biochem, 271,
3146-3154.
|
 |
|
|
|
|
 |
H.Maughan,
B.Galeano,
and
W.L.Nicholson
(2004).
Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination.
|
| |
J Bacteriol, 186,
2481-2486.
|
 |
|
|
|
|
 |
J.Mukhopadhyay,
E.Sineva,
J.Knight,
R.M.Levy,
and
R.H.Ebright
(2004).
Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel.
|
| |
Mol Cell, 14,
739-751.
|
 |
|
|
|
|
 |
M.Kim,
E.Wolff,
T.Huang,
L.Garibyan,
A.M.Earl,
J.R.Battista,
and
J.H.Miller
(2004).
Developing a genetic system in Deinococcus radiodurans for analyzing mutations.
|
| |
Genetics, 166,
661-668.
|
 |
|
|
|
|
 |
M.Sasaki,
and
Y.Kurusu
(2004).
Analysis of spontaneous base substitutions generated in mutator strains of Bacillus subtilis.
|
| |
FEMS Microbiol Lett, 234,
37-42.
|
 |
|
|
|
|
 |
S.Duigou,
S.D.Ehrlich,
P.Noirot,
and
M.F.Noirot-Gros
(2004).
Distinctive genetic features exhibited by the Y-family DNA polymerases in Bacillus subtilis.
|
| |
Mol Microbiol, 54,
439-451.
|
 |
|
|
|
|
 |
S.F.Tolić-Nørrelykke,
A.M.Engh,
R.Landick,
and
J.Gelles
(2004).
Diversity in the rates of transcript elongation by single RNA polymerase molecules.
|
| |
J Biol Chem, 279,
3292-3299.
|
 |
|
|
|
|
 |
S.Mennecier,
G.Coste,
P.Servant,
A.Bailone,
and
S.Sommer
(2004).
Mismatch repair ensures fidelity of replication and recombination in the radioresistant organism Deinococcus radiodurans.
|
| |
Mol Genet Genomics, 272,
460-469.
|
 |
|
|
|
|
 |
T.Inaoka,
K.Takahashi,
H.Yada,
M.Yoshida,
and
K.Ochi
(2004).
RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis.
|
| |
J Biol Chem, 279,
3885-3892.
|
 |
|
|
|
|
 |
D.M.Rothstein,
A.D.Hartman,
M.H.Cynamon,
and
B.I.Eisenstein
(2003).
Development potential of rifalazil.
|
| |
Expert Opin Investig Drugs, 12,
255-271.
|
 |
|
|
|
|
 |
D.W.Selinger,
R.M.Saxena,
K.J.Cheung,
G.M.Church,
and
C.Rosenow
(2003).
Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation.
|
| |
Genome Res, 13,
216-223.
|
 |
|
|
|
|
 |
I.Artsimovitch,
C.Chu,
A.S.Lynch,
and
R.Landick
(2003).
A new class of bacterial RNA polymerase inhibitor affects nucleotide addition.
|
| |
Science, 302,
650-654.
|
 |
|
|
|
|
 |
K.S.Murakami,
and
S.A.Darst
(2003).
Bacterial RNA polymerases: the wholo story.
|
| |
Curr Opin Struct Biol, 13,
31-39.
|
 |
|
|
|
|
 |
N.Opalka,
M.Chlenov,
P.Chacon,
W.J.Rice,
W.Wriggers,
and
S.A.Darst
(2003).
Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase.
|
| |
Cell, 114,
335-345.
|
 |
|
|
|
|
 |
S.Borukhov,
and
E.Nudler
(2003).
RNA polymerase holoenzyme: structure, function and biological implications.
|
| |
Curr Opin Microbiol, 6,
93.
|
 |
|
|
|
|
 |
T.J.Santangelo,
R.A.Mooney,
R.Landick,
and
J.W.Roberts
(2003).
RNA polymerase mutations that impair conversion to a termination-resistant complex by Q antiterminator proteins.
|
| |
Genes Dev, 17,
1281-1292.
|
 |
|
|
|
|
 |
U.Dreses-Werringloer,
I.Padubrin,
L.Köhler,
and
A.P.Hudson
(2003).
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.
|
| |
Antimicrob Agents Chemother, 47,
2316-2318.
|
 |
|
|
|
|
 |
V.Epshtein,
and
E.Nudler
(2003).
Cooperation between RNA polymerase molecules in transcription elongation.
|
| |
Science, 300,
801-805.
|
 |
|
|
|
|
 |
V.Epshtein,
F.Toulmé,
A.R.Rahmouni,
S.Borukhov,
and
E.Nudler
(2003).
Transcription through the roadblocks: the role of RNA polymerase cooperation.
|
| |
EMBO J, 22,
4719-4727.
|
 |
|
|
|
|
 |
W.L.Ng,
K.M.Kazmierczak,
G.T.Robertson,
R.Gilmour,
and
M.E.Winkler
(2003).
Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors.
|
| |
J Bacteriol, 185,
359-370.
|
 |
|
|
|
|
 |
A.J.Vogler,
J.D.Busch,
S.Percy-Fine,
C.Tipton-Hunton,
K.L.Smith,
and
P.Keim
(2002).
Molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus.
|
| |
Antimicrob Agents Chemother, 46,
511-513.
|
 |
|
|
|
|
 |
B.W.Trautinger,
and
R.G.Lloyd
(2002).
Modulation of DNA repair by mutations flanking the DNA channel through RNA polymerase.
|
| |
EMBO J, 21,
6944-6953.
|
 |
|
|
|
|
 |
J.E.Bandow,
H.Brötz,
and
M.Hecker
(2002).
Bacillus subtilis tolerance of moderate concentrations of rifampin involves the sigma(B)-dependent general and multiple stress response.
|
| |
J Bacteriol, 184,
459-467.
|
 |
|
|
|
|
 |
J.F.Kugel,
and
J.A.Goodrich
(2002).
Translocation after synthesis of a four-nucleotide RNA commits RNA polymerase II to promoter escape.
|
| |
Mol Cell Biol, 22,
762-773.
|
 |
|
|
|
|
 |
J.Yuzenkova,
M.Delgado,
S.Nechaev,
D.Savalia,
V.Epshtein,
I.Artsimovitch,
R.A.Mooney,
R.Landick,
R.N.Farias,
R.Salomon,
and
K.Severinov
(2002).
Mutations of bacterial RNA polymerase leading to resistance to microcin j25.
|
| |
J Biol Chem, 277,
50867-50875.
|
 |
|
|
|
|
 |
K.S.Murakami,
S.Masuda,
E.A.Campbell,
O.Muzzin,
and
S.A.Darst
(2002).
Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex.
|
| |
Science, 296,
1285-1290.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Cramer
(2002).
Multisubunit RNA polymerases.
|
| |
Curr Opin Struct Biol, 12,
89-97.
|
 |
|
|
|
|
 |
S.A.Darst,
N.Opalka,
P.Chacon,
A.Polyakov,
C.Richter,
G.Zhang,
and
W.Wriggers
(2002).
Conformational flexibility of bacterial RNA polymerase.
|
| |
Proc Natl Acad Sci U S A, 99,
4296-4301.
|
 |
|
|
|
|
 |
S.A.Joyce,
and
C.J.Dorman
(2002).
A Rho-dependent phase-variable transcription terminator controls expression of the FimE recombinase in Escherichia coli.
|
| |
Mol Microbiol, 45,
1107-1117.
|
 |
|
|
|
|
 |
R.Landick
(2001).
RNA polymerase clamps down.
|
| |
Cell, 105,
567-570.
|
 |
|
|
|
|
 |
S.A.Darst
(2001).
Bacterial RNA polymerase.
|
| |
Curr Opin Struct Biol, 11,
155-162.
|
 |
|
|
|
|
 |
T.Heyduk,
and
A.Niedziela-Majka
(2001).
Fluorescence resonance energy transfer analysis of escherichia coli RNA polymerase and polymerase-DNA complexes.
|
| |
Biopolymers, 61,
201-213.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |